Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Imatinib Mesylate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01564836
What this trial is testing

Discontinuation Study of Imatinib in Adult CP CML Patients Who Have a Complete Molecular Response to Imatinib

Who this might be right for
Chronic Myeloid LeukemiaImatinibComplete Molecular Response
Seoul St. Mary's Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT07096609
What this trial is testing

Lenvatinib After Progression on Imatinib, Sunitinib, and Regorafenib for GIST Patients

Who this might be right for
GIST
Asan Medical Center 48
Early research (Phase 1)Study completedNCT00100997
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate

Who this might be right for
Leukemia
Jonsson Comprehensive Cancer Center
Very early researchStudy completedNCT05816785
What this trial is testing

Pilot Study of Imatinib Cetuximab Combo for H & N Cancer

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of Head and Neck
University of Wisconsin, Madison 15
Testing effectiveness (Phase 2)Ended earlyNCT00323791
What this trial is testing

Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
University of Medicine and Dentistry of New Jersey 100
Early research (Phase 1)Study completedNCT00424385
What this trial is testing

Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC)

Who this might be right for
Prostate Cancer
Oncology Specialists, S.C. 17
Testing effectiveness (Phase 2)Study completedNCT00219726
What this trial is testing

Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation

Who this might be right for
Chronic Myeloid Leukemia
Poitiers University Hospital 30
Not applicableEnrolling By InvitationNCT06646978
What this trial is testing

Long-term Risk of Second Primary Malignancies for Chronic Myeloid Leukaemia in the French Imatinib-based SPIRIT Trial

Who this might be right for
Chronic Myeloid Leukemia (CML)
Poitiers University Hospital 787
Testing effectiveness (Phase 2)Study completedNCT00278876
What this trial is testing

Adjuvant Imatinib in High-risk Gastrointestinal Stromal Tumor (GIST) With C-kit Mutation

Who this might be right for
SarcomaGastrointestinal Stromal Tumors
Asan Medical Center 47
Testing effectiveness (Phase 2)Ended earlyNCT05160168
What this trial is testing

THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors (GIST)Neoplasms, Connective TissueNeoplasms, Connective and Soft Tissue+6 more
Theseus Pharmaceuticals 32
Testing effectiveness (Phase 2)Study completedNCT03944304
What this trial is testing

Paclitaxel in Patients With GIST With Low P-glycoprotein Expression After Failure of at Least Imatinib and Sunitinib, and Regorafenib.

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT00769327
What this trial is testing

Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 129
Post-approval studies (Phase 4)Ended earlyNCT05071482
What this trial is testing

Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL

Who this might be right for
Acute Leukemia
Institute of Hematology & Blood Diseases Hospital, China 39
Testing effectiveness (Phase 2)UnknownNCT01802450
What this trial is testing

Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase

Who this might be right for
Chronic Myeloid Leukemia
PETHEMA Foundation 18
Large-scale testing (Phase 3)Study completedNCT00041197
What this trial is testing

Imatinib Mesylate in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed By Surgery

Who this might be right for
Gastrointestinal Stromal Tumor
National Cancer Institute (NCI) 732
Large-scale testing (Phase 3)Study completedNCT00116935
What this trial is testing

Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Sarcoma
Scandinavian Sarcoma Group 400
Early research (Phase 1)Study completedNCT00446316
What this trial is testing

Effect of Antacids on Gleevec® in Healthy Volunteers

Who this might be right for
Healthy
University of Pittsburgh 12
Large-scale testing (Phase 3)Study completedNCT00760877
What this trial is testing

Nilotinib Versus Standard Imatinib (400/600 mg Every Day (QD)) Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction (RQ-PCR)

Who this might be right for
CHRONIC MYELOGENOUS LEUKEMIA
Novartis Pharmaceuticals 207
Testing effectiveness (Phase 2)Study completedNCT00028002
What this trial is testing

Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumor
National Cancer Institute (NCI) 63
Testing effectiveness (Phase 2)UnknownNCT00146913
What this trial is testing

AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year

Who this might be right for
Chronic Myeloid Leukemia
Hospices Civils de Lyon 30
Next Page